These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4363475

  • 1. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB.
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract] [Full Text] [Related]

  • 2. Pathophysiology of hyperuricemia in primary gout.
    Wyngaarden JB.
    Trans Am Clin Climatol Assoc; 1970 May; 81():161-73. PubMed ID: 4331016
    [No Abstract] [Full Text] [Related]

  • 3. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O, Wyngaarden JB, Starmer CF.
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [Abstract] [Full Text] [Related]

  • 4. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA, Meyer LJ, Kostel PJ, Seegmiller JE.
    Adv Exp Med Biol; 1973 Oct; 41():307-15. PubMed ID: 4364688
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.
    Benke PJ, Herrick N.
    Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247
    [No Abstract] [Full Text] [Related]

  • 11. Mutant phosphoribosylpyrophosphate synthetase in two gouty siblings with excessive purine production.
    Sperling O, Persky-Brosh S, Boer P, De Vries A.
    Adv Exp Med Biol; 1973 Apr; 41():299-305. PubMed ID: 4364687
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells.
    Reem GH.
    J Pharmacol Exp Ther; 1974 Oct; 191(1):1-9. PubMed ID: 4371231
    [No Abstract] [Full Text] [Related]

  • 13. Pathophysiology of purine metabolism in man.
    Kelley WN.
    Enzyme; 1974 Oct; 18(3):161-75. PubMed ID: 4841658
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.
    Sperling O, Persky-Brosh S, Boer P, De Vries A.
    Biochem Med; 1973 Jun; 7(3):389-95. PubMed ID: 4351826
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical biochemistry of gout].
    Greiling H.
    Dtsch Med J; 1969 May 27; 20(10):336-41. PubMed ID: 5396909
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The kinetics of intramolecular distribution of 15N in uric acid following administration of 15N-glycine: preferential labeling of N-(3+9) of uric acid in primary gout and a reappraisal of the "glutamine hypothesis".
    Sperling O, Wyngaarden JB, Starmer CF.
    Adv Exp Med Biol; 1974 May 27; 41():371-93. PubMed ID: 4832561
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.